Showing results (1261-1270 of 1,320) with videos related to

Sort By:
Pageof 132
The Lancet. Infectious Diseases|March 17, 2022
Field performance of three Ebola rapid diagnostic tests used during the 2018-20 outbreak in the eastern Democratic Republic of the Congo: a retrospective, multicentre observational studyDaniel Mukadi-Bamuleka, Junior Bulabula-Penge, Anja De Weggheleire, et al.
Mbio|June 1, 2021
Potent Killing of Pseudomonas aeruginosa by an Antibody-Antibiotic ConjugateKimberly K Kajihara, Homer Pantua, Hilda Hernandez-Barry, et al.
Emerging Infectious Diseases|March 30, 2026
Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus Infection in Humans and Domestic Ruminants, Democratic Republic of the CongoBoniface Pongombo Lombe, Yannick Munyeku-Bazitama, Gracia Kashitu-Mujinga, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 16, 2018
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Iscience|January 5, 2026
A mechanism for the disrupted redox regulation of vascular contractility during agingLeonardo Y Tanaka, Lucas F Gutierre, Ricardo C Massucatto, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 14, 2018
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2022
A ridge-to-reef ecosystem microbial census reveals environmental reservoirs for animal and plant microbiomesAnthony S Amend, Sean O I Swift, John L Darcy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 8, 2019
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 8, 2018
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Plos Genetics|April 18, 2013
A nonsynonymous polymorphism in semaphorin 3A as a risk factor for human unexplained cardiac arrest with documented ventricular fibrillationYukiko Nakano, Kazuaki Chayama, Hidenori Ochi, et al.
Pageof 132